Gennex Laboratories Limited (BOM:531739)
8.92
-0.16 (-1.76%)
At close: Jul 27, 2026
Gennex Laboratories Market Cap
Gennex Laboratories has a market cap or net worth of 2.17 billion as of July 28, 2026. Its market cap has decreased by -26.71% in one year.
Market Cap
2.17B
Enterprise Value
2.54B
Revenue
1.73B
Ranking
n/a
PE Ratio
11.71
Stock Price
8.92
ChartMarket Cap Chart
Since January 2, 2002, Gennex Laboratories's market cap has increased from 61.80M to 2.17B, an increase of 3,406.42%. That is a compound annual growth rate of 15.57%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 28, 2026 | 2.18B | -32.85% |
| Dec 31, 2025 | 3.25B | -12.43% |
| Dec 31, 2024 | 3.71B | 24.52% |
| Dec 29, 2023 | 2.98B | 160.77% |
| Dec 30, 2022 | 1.14B | -18.17% |
| Dec 31, 2021 | 1.40B | 135.61% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Everest Organics | 2.82B |
| Astonea Labs | 2.80B |
| Ambalal Sarabhai Enterprises | 2.49B |
| Sat Kartar Life | 2.15B |
| Coral Laboratories | 2.08B |
| Kerala Ayurveda | 1.97B |
| Oxygenta Pharmaceutical | 1.88B |
| Sanjivani Paranteral | 1.83B |